Midlife Plasma Aβ and Late-Life Risk of Cognitive Impairment: The Atherosclerosis Risk in Communities Study

Plasma-based biomarkers of amyloid beta (Aβ), a neuropathological hallmark of Alzheimer’s disease, show promise in predicting cognitive impairment and mapping onto cerebral amyloidosis, but little is known about how midlife plasma Aβ associates with late-life cognitive outcomes. Midlife plasma varia...

Descripción completa

Detalles Bibliográficos
Autores principales: Sullivan, Kevin, Blackshear, Chad, Sharrett, A Richey, Gottesman, Rebecca, Knopman, David, Windham, B Gwen, Griswold, Michael, Mosley, Thomas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7740202/
http://dx.doi.org/10.1093/geroni/igaa057.810

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7740202/
http://dx.doi.org/10.1093/geroni/igaa057.810

Ejemplares similares